A big pill to swallow
Article Abstract:
Glaxo shares have been affected by concern over a patent expiry in the US for Zantac, the company's ulcer treatment. Stockbrokers are divided in their views on Glaxo shares. NatWest Securities sees Glaxo's shares as fairly priced, while James Capel argues that they are overvalued, and Societe Generale Strauss Turnbull advises investors to buy the shares in Feb 1995. Nikko Europe argues for a hold, and sees possible cost reduction, but there should be evidence that Wellcome, for which Glaxo has made a bid, will be integrated into the group.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Glaxo will surge by '99
Article Abstract:
Glaxo Wellcome has warned that earnings growth will be subdued in the two years from 1997, but this could change in 1999. Four analysts from a sample of six rate the company's shares a buy and two rate them a hold. The buyers are BZW, Morgan Stanley, Goldman Sachs and Societe Generale Strauss Turnbull. Goldman Sachs does not see US sales of Zantac as likely to fall by as much as Glaxo's worst forecasts. The holders are Merrill Lynch and Lehman Brothers.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Pharmagene
Article Abstract:
UK drug discovery firm Pharmagene has strong growth potential which is not reflected in its share price, making its shares a good tip. Pharmagene could reap high profits from its TargetEvaluator drug-discovery database.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Trading in insurance windfalls. No surrender. With and without performance
- Abstracts: Revealing its true strength. Graseby
- Abstracts: Softening up the market. Misys. Catch a falling knife
- Abstracts: Sailing towards troubled waters. Changing Signals on the Kursk Lift. The Zumwalt-class destroyers
- Abstracts: Why recession isn't a problem. Get ready for the recession of 1998. Recession fears overplayed